The 2026 national basic medical insurance drug catalogue negotiation and commercial insurance innovative drug catalogue price negotiation work officially began today at the Beijing National People's Congress Convention Center. At around 7:30 a.m., corporate negotiators had already arrived at the scene to wait. It is worth noting that this year's national talks have further strengthened pre-negotiation communication, with reference to the gradual implementation of new mechanisms such as pre-drug communication and pre-declaration, and the time line for enterprises to lay out medical insurance continues to move forward. The National Health Insurance Administration previously revealed that in the 2026 basic medical insurance catalogue adjustment, a total of 664 drug generic names were declared, and in the end, 601 passed the formal review; a total of 62 drug generic name declarations and 58 passed the formal review. Many new local innovative drug stars and leading companies, such as Baili Tianheng, Keji Pharmaceutical, Baiji Shenzhou, Sansheng Guojian, and Zhixiang Jintai, have made declarations. The industry expects that this round of on-site negotiations and bidding for the adjustment of the national health insurance catalogue and commercial insurance innovative drug catalogue price negotiations will continue for 4 to 5 days.

The 2026 national basic medical insurance drug catalogue negotiation and commercial insurance innovative drug catalogue price negotiation work officially began today at the Beijing National People's Congress Convention Center. At around 7:30 a.m., corporate negotiators had already arrived at the scene to wait. It is worth noting that this year's national talks have further strengthened pre-negotiation communication, with reference to the gradual implementation of new mechanisms such as pre-drug communication and pre-declaration, and the time line for enterprises to lay out medical insurance continues to move forward. The National Health Insurance Administration previously revealed that in the 2026 basic medical insurance catalogue adjustment, a total of 664 drug generic names were declared, and in the end, 601 passed the formal review; a total of 62 drug generic name declarations and 58 passed the formal review. Many new local innovative drug stars and leading companies, such as Baili Tianheng, Keji Pharmaceutical, Baiji Shenzhou, Sansheng Guojian, and Zhixiang Jintai, have made declarations. The industry expects that this round of on-site negotiations and bidding for the adjustment of the national health insurance catalogue and commercial insurance innovative drug catalogue price negotiations will continue for 4 to 5 days.